A new process for synthesising anti-inflammatory drugs such as
ibuprofen could offer an environmentally friendly means of avoiding
the 50 per cent waste seen with current methods of synthesis.
In the world of chemistry the majority of reactions are well known
and have been around for a very long time producing similar
compounds. It is not very often that a completely new reaction
methodology comes along which can turn something...
The fine chemicals division of Japanese contract manufacturer Daiso
has taken out a license to a highly-selective technology used to
synthesise chiral molecules.
Pharmaceutical services group Almac Sciences has teamed up with
enzyme catalyst firm BioCatalytics on process development and
manufacture of chiral intermediates and active pharmaceutical
ingredients (APIs).
Targeting the market for enantiomerically pure drugs, SAFC, a
custom manufacturing group within Sigma-Aldrich, has acquired
Honeywell International's Iropharm unit in Arklow, Ireland.
Warwick Analytical Services has made available a service that
allows the investigation and measurement of the optical activity of
samples with an accuracy of +/- 0.002 degrees for optical rotations
of less than 1 degree.
Solvias debuted its new 80-member ligand kit at CPhI 2005, offering
manufacturers increased flexibility in active pharmaceutical
ingredient (API) development and manufacturing.
Chiral Quest has opened up a production facility near Shanghai in
China, to tap into the trend by pharmaceutical companies to site
manufacturing operations in the region, writes Phil Taylor.
Chiral Quest has forged an alliance with DSM to accelerate the
take-up of its catalysis products, used in the synthesis of
chemicals and pharmaceuticals.
Irish start-up Celtic Catalysts believes it can tackle two of the
major obstacles holding back the use of catalysts to make chiral
drugs - the strong patent positions of existing players and
difficulties in scale-up - with its platform...
Bayer Chemicals became a separate legal entity from the rest of the
Bayer group just over one month ago, having operated as a virtual
company since the middle of 2002. The company gave its first press
conference at the CPhI meeting...
The demands of the pharmaceutical industry are driving strong
growth in the market for outsourced chiral technologies, according
to a report from Frost & Sullivan
